Pablo Avanzas • Peter Clemmensen
Editors

2014

Acute coronary syndromes (ACS) require rapid intervention with pharmacologic therapies to treat and prevent coronary thromboembolism, and is essential to prepare the patient for revascularization procedures, especially percutaneous coronary intervention. The aims of treatment are to preserve patency of the coronary artery, augment blood flow through stenotic lesions, and reduce myocardial oxygen demand. Conventional treatment includes anti-ischemic, antiplatelet and anticoagulant therapy.